Prostate-specific antigen (PSA) screening reduces prostate cancer (PCa) mortality; however such screening may lead to harm in terms of overdiagnosis and overtreatment. Although organized screening with the blood test prostate-specific antigen (PSA) (with different thresholds) had significantly higher sensitivity than the strategy with In the new test, sensitivity -- the percentage of men with prostate cancer who were correctly identified as having a malignancy -- was 79 percent compared to the 52 percent found in PSA testing. Objectives: To investigate the potential use of body mass index (BMI) and serum lipids in improving prostate-specific antigen (PSA) sensitivity in patients undergoing biopsy for suspicion of prostate cancer, as there is an established relationship between metabolic syndrome, obesity and serum lipids with prostate cancer.. Patients and methods: A pilot study was conducted in a tertiary referral The major shortcoming of the PSA test is its less-than-perfect sensitivity and specificity rates, despite the fact that these rates are among the highest of cancer screening tests currently in use. Approximately 25% to 33% of patients with prostate cancer have serum PSA concentrations in the normal range at the time of diagnosis, made on The Select mdx test measures the amount of two genes associated with aggressive prostate cancer. The measurement of these prostate cancer specific genes in combination with traditional clinical risk factors—such as your age, PSA (prostate-specific antigen) level, prostate volume, family history of prostate cancer, and the outcome of a digital rectal examination (DRE) results in your Select The prostate-specific antigen (PSA) test is a blood test that checks for PSA, which is a chemical that is produced by both cancerous and non-cancerous prostate tissues. The PSA test can be useful in detecting prostate cancer, monitoring its treatment, or assessing its recurrence. The PSA test can also be abnormal with benign enlargement rImm38e.

sensitivity of psa test for prostate cancer